Last reviewed · How we verify
NCT05771922
Implication of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies
trial testing High-resolution ultrasonography in Ultrasound Therapy; Complications Anomaly Central Nervous System Diseases in 150 participants. Currently enrolling.
1 March 2026
Quick facts
| Lead sponsor | Woman's Health University Hospital, Egypt |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 30 November 2024 |
| Primary completion | 1 March 2026 |
| Estimated completion | 20 March 2026 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- High-resolution ultrasonography
Conditions studied
- Ultrasound Therapy; Complications Anomaly Central Nervous System Diseases — all drugs for Ultrasound Therapy; Complications Anomaly Central Nervous System Diseases →
Sponsor
Woman's Health University Hospital, Egypt
Who can join
Adults 20 to 28, female only, with Ultrasound Therapy; Complications Anomaly Central Nervous System Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The fetal CNS screening examination during the mid-trimester scan in low-risk pregnancies should include evaluation of the fetal head and spine, using transabdominal sonography. Evaluation of two axial planes allows visualization of the relevant cerebral structures to assess the anatomic integrity of the fetal brain.These planes are commonly referred to as the transventricular and transcerebellar planes. A third plane, the so-called transthalamic plane, is frequently added, mostly for the purpose of biometry. Structures that should be noted in the routine examination include the lateral ventricles, the cerebellum, the cisterna magna, and the cavum septi pellucidi (CSP). Head shape and brain texture should also be noted on these views.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05771922
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High-resolution ultrasonography
Trials testing the same drug.
- NCT05778279 — Role of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies · recruiting
Other Woman's Health University Hospital, Egypt trials
Trials by the same sponsor.
- NCT05778279 — Role of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies · recruiting
- NCT05734287 — The Frequency of Polycystic Ovary Syndrome Among Young Reproductive Females Presenting With Hyperandrogenism: a Mixed Co · recruiting
- NCT04357054 — Darwish Hysteroscopic Test (Hysteroscopic Bubble Suction and Tubal Peristalsis of Darwish Triad) in Myomatous Uterus · NA · unknown
- NCT04825041 — Efficacy of Hysteroscopic Bubble Test, Flow Test and Peristalsis Test. · completed
- NCT05042895 — Hysteroscopic Findings in Ovarian Polycystic and Unexplained Infertile Women. · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05771922 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Woman's Health University Hospital, Egypt
- Last refreshed: 24 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05771922.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing